The largest database of trusted experimental protocols

Accuri c6 analysis software

Manufactured by BD
Sourced in United States

The BD Accuri™ C6 analysis software is a comprehensive data analysis tool designed to work in conjunction with BD Accuri™ C6 flow cytometers. The software provides users with the ability to analyze and interpret data generated from flow cytometry experiments.

Automatically generated - may contain errors

5 protocols using accuri c6 analysis software

1

Flow Cytometry Analysis of Oxy Effects on MCF-7aro Cell Cycle

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the effects of Oxy on MCF-7aro cell cycle progression, the DNA content was assessed by flow cytometry. MCF-7aro cells (7 × 105 cells/mL) stimulated with T (1 nM) were incubated with Oxy (1 and 2.5 µM) for 3 days. Cells only treated with T were considered as control. After the incubation period, cells were fixed with 70% cold ethanol and stained with a DNA staining solution (5 µg/mL Propidium Iodide (PI), 0.1% Triton X-100 and 200 µg/mL DNase-free RNase A (Sigma-Aldrich Co., Saint Louis, MI, USA)), as previously described [19 (link)]. DNA content was analyzed by flow cytometry based on the acquisition of 40 000 events in a BD Accuri™ C6 cytometer (San Jose, CA, USA), equipped with a BD Accuri™ C6 analysis software. Detectors for the three fluorescence channels (FL-1, FL-2 and FL-3) and for forward (FSC) and side (SSC) light scatter were set on a linear scale. Debris, cell doublets and aggregates were gated out using a two-parameter plot of FL-2-Area to FL-2-Width of PI fluorescence. Data were analyzed using the BD Accuri™ C6 analysis software. The anti-proliferative effects were indicated by the percentage of cells in G0/G1, S and G2/M phases of the cell cycle.
+ Open protocol
+ Expand
2

Evaluating G's Impact on MCF-7aro Cell Cycle

Check if the same lab product or an alternative is used in the 5 most similar protocols
To study the effects of G on MCF-7aro cell cycle progression, the DNA content was assessed through labeling with propidium iodide (PI) and by performing flow cytometry. Cells (7 × 105 cells/mL) stimulated with T (1 nM) were incubated with G (1 µM), Exe (10 µM), or with G plus Exe, for 3 days. Cells only treated with T were considered the control group. Following treatments, cells were fixed with cold 70% EtOH and stained with a DNA labeling solution (Propidium Iodide at 5 μg/mL, 0.1% Triton X-100 and 200 μg/mL DNase-free RNAse A) (Sigma–Aldrich Co., Saint Louis, MO, USA), as previously described [39 (link)]. DNA content was analyzed by flow cytometry based on the acquisition of 40,000 events in a BD Accuri C6 cytometer (San Jose, CA, USA). Detectors for the three fluorescence channels (FL-1, FL-2, and FL-3) and for forward (FSC) and side (SSC) light scatter were set on a linear scale. Debris, cell doublets, and aggregates were gated out using a two-parameter plot of FL-2-Area to FL-2-Width of PI fluorescence. Data were analyzed using the BD Accuri™ C6 analysis software. The antiproliferative effects were indicated by the percentage of cells in the G0/G1, S, and G2/M phases of the cell cycle.
+ Open protocol
+ Expand
3

Cell Cycle Analysis of NET Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
NET cells were grown and treated with WNT974 (1–16 µM) for 72 h and then harvested through trypsinization, centrifugation and two washing steps in phosphate-buffered saline (PBS). After that, the cells were re-suspended in Nicoletti solution containing propidium iodide (Sigma-Aldrich, Taufkirchen, Germany) and then analyzed with the BD Accuri C6 flow cytometer and quantified using BD Accuri C6 Analysis software (BD Biosciences, Heidelberg, Germany) for cell cycle distribution. All experiments, consisting of technical triplicates, were repeated at least three times.
+ Open protocol
+ Expand
4

Quantifying Mot-2 Expression in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
LoVo and HCT‐116 cancer cells were treated with different concentrations of VTD dissolved in DMSO. After 72 h of treatment, cells were washed twice in ice‐cold PBS, trypsinized, and fixed in 70% ethanol overnight at −20 °C, followed by permeabilization with PBS containing 0.25% Triton X‐100 for 20 min at 4 °C. Then, cells were blocked with 2% BSA in PBS and incubated with anti‐mot‐2 antibody (1 : 100 dilution) per 106 cells for 60 min on ice. Following washing with PBS, cells were incubated with Alexa Fluor 546 donkey anti‐mouse IgG antibody (purple‐Thermo Fisher Scientific, diluted 1 : 50) for 30 min on ice, washed, and resuspended in PBS. Stained cells were analyzed using a bd accuri c6, and the collected data were analyzed using bd accuri c6 analysis software (BD biosciences, Franklin Lakes, NJ, USA).
+ Open protocol
+ Expand
5

Multimodal Cellular Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
See Key Resources Table for sources for reagents, cell lines, etc. All imaging experiments were performed on a Zeiss LSM 800 confocal laser scanning microscope equipped with 40X 1.4 NA Plan Apochromat objectives, 405, 488, 561, and 640 nm solid-state lasers, and two GaAsP PMT detectors, using the Zeiss Zen Blue 2.3 software. All image analysis was performed using FIJI/ImageJ. Flow cytometry experiments, except for Figs. 1E and S1, was performed on a BD Accuri C6 flow cytometer, and analysis was performed using the BD Accuri C6 analysis software. Flow cytometry experiment for Figs. 1E and S1 was performed on a Thermo Fisher Attune NxT Flow Cytometer equipped with 405, 488, 561, 637 nm lasers using 480 and 647 dual lasers. Luminescence measurements were performed using a Tecan Infinite M1000 Microplate Reader (cat # 30034301).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!